Skip to content
HomeLatest newsPersonal storiesA dad’s story: How adopting my daughter from China changed my life
Sneed and his daughter, Karis
Sneed and his daughter, Karis

A dad’s story: How adopting my daughter from China changed my life

Sneed and his daughter, Karis

A whirlwind of emotions. That’s what Michael Sneed felt when he brought his daughter, Karis, home from an adoption center in China.

“That first night, [I remember] having it all hit me and going, ‘Wow, this is our child,’ ” he recalls.

Sneed, Executive Vice President, Global Corporate Affairs & Chief Communication Officer at Johnson & Johnson, adopted then 15-month-old Karis from a Hong Kong orphanage in 2002. At the time, he had been traveling to China quite frequently for work when he proposed the idea of adopting a baby from the country to his wife, Ann Sneed.

The couple already had two children—a daughter named Taylor and a son, Logan—and as Sneed recalls, “We felt it was right. It felt good for us as a family.”

Johnson & Johnson has a long history of caring for employees—and their families. Recently, the company announced enhancements to its family benefits in the U.S., including surrogacy assistance and adoption assistance, so employees like Sneed can fulfill their dreams of building a family.

“It’s industry-leading in terms of the vision and the impact of the support that we provide for the people of Johnson & Johnson,” Sneed says.

As you will see in this video chronicling Sneed’s journey as an adoptive parent, a loving and nurturing family can take all shapes and forms.

“Family’s about extended love,” Ann Sneed says. “And whether it’s biological or adopted, it’s really supporting these children, helping them grow, building a legacy.”

hqdefault.jpg
Johnson & Johnson Debuts a Suite Enhanced Family Benefits

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.